Search results
Results from the WOW.Com Content Network
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances.
Rifampicin is of the rifamycin group of antibiotics. [3] It works by decreasing the production of RNA by bacteria. [3] Rifampicin was discovered in 1965, marketed in Italy in 1968, and approved in the United States in 1971. [5] [6] [7] It is on the World Health Organization's List of Essential Medicines. [8]
Pages in category "Rifamycin antibiotics" The following 7 pages are in this category, out of 7 total. This list may not reflect recent changes. R. Rifabutin;
Rifaximin, is a non-absorbable, broad spectrum antibiotic mainly used to treat travelers' diarrhea.It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in over more than 30 countries for the treatment of a variety of gastrointestinal diseases like irritable bowel syndrome, and hepatic encephalopathy.
It produces the rifamycin antibiotics (e.g., rifamycin SV), which are used to treat mycobacterial diseases such as tuberculosis and leprosy. [2] The type strain of Amycolatopsis rifamycinica (DSM 46095) has been reclassified several times. When it was first isolated from a French soil sample in 1957, it was identified as Streptomyces ...
This page was last edited on 5 November 2023, at 03:47 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The hope of a fixed-dose combination pill is to increase the likelihood that people will take all of three medications. [5] Also, if people forget to take one or two of their drugs, they might not then develop resistance to the remaining drugs.
This page was last edited on 20 June 2009, at 20:03 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may ...